ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1275

Dual-Energy CT for the Diagnosis of Gout: A Prospective Study in Patients with No Prior History of Gout

Mihaela Gamala1, Johannes W. G. Jacobs2, Suzanne Linn-Rasker3, Maarten Nix4, Ben Heggelman4, Pieternel Pasker5, Jacob van Laar6 and Ruth Klaasen3, 1Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Rheumatolgy & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3Rheumatology, Meander Medical Center Amersfoort, Amersfoort, Netherlands, 4Radiology, Meander Medical Center Amersfoort, Amersfoort, Netherlands, 5Meander Academy, Meander Medical Center Amersfoort, Amersfoort, Netherlands, 6Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands, Utrecht, Netherlands

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Gout is associated with joint damage, and increased cardiovascular morbidity, so to diagnose and treat gout early is important. However, joint aspiration and microscopy not always yield the diagnosis. The latest diagnostic technique to visualize monosodium uric acid (MSU) depositions is Dual Energy CT scan (DECT).1

We purpose to assess the sensitivity and specificity of DECT for diagnosing gout in patients with unclassified arthritis.

Methods: We included 87 consecutive patients with acute mono or oligo arthritis without prior gout diagnosis who presented to the outpatient clinic of the Department of Rheumatology of Meander Medical Centre, Amersfoort, the Netherlands, ClinicalTrials.gov number NCT03038386. Seven patients dropped out, see Figure. Patients underwent aspiration of the arthritic joint for the detection of MSU crystals (see Table) and a DECT scan of hands and wrists, knees, ankles and feet. The synovial fluid result for MSU crystals was the gold standard for gout.

Results: For demographic and clinical characteristics of the patients see Table, and for study data and outcomes see Figure. The sensitivity and specificity of DECT for gout deposition in the index joint were 0.58 (95% CI 0.43-0.72) and 0.75 (95% CI 0.57-0.89), respectively, with an area under the ROC curve of 0.67 (95% CI 0.55-0.79), p<0.05. When classifying DECT as positive if deposition was observed at the index joint and/or in other locations, sensitivity was higher: 0.77 (95% CI 0.63-0.88), but specificity lower: 0.69 (95% CI 0.48-0.86).

Conclusion: These preliminary data show the diagnostic value of DECT in patients with acute unclassified mono or oligo arthritis. Probably, DECT sensitivity is underestimated by false negative MSU results due to a sampling error, because of incorrect aspiration, or extra-articular locations of the gout, e.g. around tendons.

Table. The demographic and clinical characteristics of the patients (n=80) included in the study

Patients MSU positive (n=48)

Patients MSU negative (n=32)

Age in years, mean (SD),

59.0 (15.6)

63.1 (13.0)

Sex, N (%)

   Male

41   (85.4)

25   (78.1)

   Female

7    (14.6)

7    (21.9)

Arthritic joint aspirated (N, %)

   MTP1

29   (60.4)

6    (18.8)

   Other joints

19   (39.6)

26   (81.2)

Period between 1th arthritis attack and baseline visit in months, median (IQR)*

12 (56)

6 (35.8)

Serum uric acid (µmol/L) mean (SD)

465.72  (120.65)

403.50  (109.71)

* according to patient


Disclosure: M. Gamala, None; J. W. G. Jacobs, None; S. Linn-Rasker, None; M. Nix, None; B. Heggelman, None; P. Pasker, None; J. van Laar, Arthrogen, MSD, Pfizer, Eli Lelly, BMS, Astra Zeneca, Roche-Genentech, 2, 5; R. Klaasen, None.

To cite this abstract in AMA style:

Gamala M, Jacobs JWG, Linn-Rasker S, Nix M, Heggelman B, Pasker P, van Laar J, Klaasen R. Dual-Energy CT for the Diagnosis of Gout: A Prospective Study in Patients with No Prior History of Gout [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/dual-energy-ct-for-the-diagnosis-of-gout-a-prospective-study-in-patients-with-no-prior-history-of-gout/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dual-energy-ct-for-the-diagnosis-of-gout-a-prospective-study-in-patients-with-no-prior-history-of-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology